Evidence map›Paper›PMID 19200758›Full record

ArticleImmunity2009

Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells.

Susan Johnson, Yifan Zhan, Robyn M Sutherland, Adele M Mount, Sammy Bedoui, Jamie L Brady, Emma M Carrington, Lorena E Brown, Gabrielle T Belz, William R Heath and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 98 citations in OpenAlex.

  1. Inhibition of CD154:CD11b interactions using a novel nanotherapeutic improves allograft survival.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Harnessing the potential of CD40 agonism in cancer therapy.Cytokine & growth factor reviews · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. CD11b is a novel alternate receptor for CD154 during alloimmunity.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  11. Article
  12. Dendritic Cell-Mediated Th2 Immunity and Immune Disorders.International journal of molecular sciences · 2019
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. CD40L Expression Allows CD8Frontiers in immunology · 2017
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Susan JohnsonAutoimmunity and Transplantation Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australiaia.
Yifan Zhan
Robyn M Sutherland
Adele M Mount
Sammy Bedoui
Jamie L Brady
Emma M Carrington
Lorena E Brown
Gabrielle T Belz
William R Heath
Andrew M Lew
Walter and Eliza Hall Institute of Medical Research · AUThe University of Melbourne · AU

Funding

REGULATION OF PERIPHERAL TOLERANCE VERSUS IMMUNITYR01AI043347 · NIAID · WALTER AND ELIZA HALL INST MEDICAL RES · PI HEATH, WILLIAM R · 1998 to 2000
$108k
NIAID NIH HHS R01 AI043347
6 · The paper itself

Abstract

CD40L (CD154) on CD4(+) T cells has been shown to license dendritic cells (DCs) via CD40 to prime cytotoxic T lymphocyte (CTL) responses. We found that the converse (CD40L on DCs) was also important. Anti-CD40L treatment decreased endogenous CTL responses to both ovalbumin and influenza infection even in the absence of CD4(+) T cells. DCs expressed CD40L upon stimulation with agonists to Toll-like receptor 3 (TLR3) and TLR9. Moreover, influenza infection, which stimulates CTLs without help, upregulated CD40L on DCs, but herpes simplex infection, which elicits CTLs through help, did not. CD40L-deficient (Cd40lg(-/-)) DCs are suboptimal both in vivo in bone marrow chimera experiments and in vitro in mixed lymphocyte reactions. In contrast, Cd40lg(-/-) CD8(+) T cells killed as effectively as wild-type cells. Thus, CD40L upregulation on DCs promoted optimal priming of CD8(+) T cells without CD4(+) T cells, providing a mechanism by which pathogens may elicit helper-independent CTL immunity.

Indexed as

AnimalsAntibodiesCD40 AntigensCD40 LigandDendritic CellsLigandsMiceMice, KnockoutT-Lymphocytes, CytotoxicT-Lymphocytes, Helper-InducerToll-Like ReceptorsUp-RegulationAntibodiesCD40 AntigensCD40 LigandLigandsToll-Like Receptors

Identifiers

PMID19200758
PMCPMC2694753
OpenAlexW2150545218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.